Amgen, Cytokinetics heart failure drug misses goal in study

AMSTERDAM (Reuters) - An experimental heart failure drug from Amgen and Cytokinetics missed its goal of improving shortness of breath in a mid-stage clinical trial, leaving its future uncertain.

via Reuters: Health News Read More Here..